Introduction
mostatic disorders or lipid metabolism, arterial trauma during transplant surgery (clamping and suturing of Along with infectious complications, cardiovascular renal artery) or pre-existing atherosclerotic patches in disease is the predominant cause of morbidity and graft arteries (especially in coronary arteries). mortality in renal transplant recipients [1, 2] . The Most attempts at preventing graft arterial disease reasons for this association of arterial disease with have failed. One notable exception has been the prorenal transplantation are complex and have not been tective efficacy of pravastatin (an inhibitor of hydroxyfully elucidated, which makes prevention difficult.
methylglutaryl coenzyme A reductase) against To progress in this field, it is essential to make a coronary disease after cardiac transplantation, through clear distinction between the arterial disease affecting a decrease in plasma cholesterol and/or in the cytotoxthe graft itself and the discrete involvement of host icity of natural killer cells [6 ] . Nonetheless, it would arteries, the mechanisms and consequences of these be premature to extend this relative success to the two pathologies being probably different.
prevention of allovasculopathy involving arteries other than the coronaries. An essential feature of graft arterial disease is that
Arterial disease of the graft
it only affects graft arteries and spares the host arteries. A specific type of arterial disease has been recognized consistently in all solid organs used in human transDiffuse arterial disease of renal transplant plantation (heart, lung, liver, pancreas or kidney) [3] .
recipients
This so called allovasculopathy often plays an important role in chronic rejection. It is characterized mainly by a diffuse thickening of the arterial intima, leading The incidence of cardiovascular diseases (coronary to small vessel obstruction. The most salient and heart disease, lower limb arterial disease, strokes) is constant features of intimal allovasculopathy are mas-about four times greater in renal transplant recipients sive sclerosis, infiltration by lymphocytes and mono-than in the general population [1] . cytes, profuse formation of foamy cells (whose One explanation could be that an allograft of any cytoplasm is stuffed with lipid vacuoles) and extracellu-solid organ may induce arterial disease in general, and lar lipid deposits. The media is also affected, although atherosclerosis in particular. The link would be either to a lesser extent. In cardiac grafts, the epicardial direct, through the immune reaction triggered by the segment of the coronary arteries exhibits diffuse athero-graft, or indirect through the immunosuppressive treatsclerotic lesions which progress rapidly. Similar lesions ments necessitated by transplantation. However, such are also present in the renal artery of kidney grafts a view is not tenable because the association with host [4] , which are responsible for stenoses that may require arterial disease has been established only in renal percutaneous angioplasty or surgery.
transplantation and does not exist in cardiac The determinants of graft arterial disease have been transplantation. studied mostly in cardiac transplantation where it is the Therefore, there must be another explanation: the predominant cause of late graft failure. The first culprit disease that initially called for renal transplantation is an immuno-inflammatory reaction. As a still contro-was the real cause of systemic arterial disease; chronic versial addendum, immunosuppression might enhance renal failure, although cured by grafting, leads to this reaction through opportunistic infections by agents irreversible arterial damage which continues to prowith an arterial tropism, such as cytomegalovirus [5] . gress on its own after transplantation. This is strongly supported by Kasiske's retrospective study [1] involving 403 renal transplant recipients over 10 years Correspondence and offprint requests to: Loïc Capron, Département (mean follow-up 46 months after transplantation). Pre-L. Capron and G. Grateau 50 ive index for the occurrence of an arterial event after diabetes mellitus and hypertension are two major determinants of chronic renal failure, which by themselves transplantation: the relative risk estimated for such an event was 3.7 in patients whose arterial disease had strongly promote the development of obstructive arterial disease; plasma lipid abnormalities resulting from the been diagnosed before renal transplantation, by comparison with recipients without such a disease. Other nephrotic syndrome act concurrently [9] .
Arterial disease in chronic renal failure cannot be analytic variables also had a significant impact on arterial prognosis, though with much lower relative viewed as a mere aggravation of atherosclerosis. The arterial lesions are generally more diffuse and distal risks except for diabetes mellitus, unsurprisingly (estimated relative risk 2.7). A more recent publication by than usual atherosclerosis (strictly defined as a focal disease of large-and medium-size arteries, with plaques the same team (706 patients, mean duration of followup 7 years) confirmed the strong predictive influence associating sclerosis and atheromatous lipid deposits).
This difference is especially obvious in lower limb of pre-existing arterial disease and diabetes [2] . The surprising fact that neither hypertension nor plasma arteries, with a predominant involvement of the distal run-off. In addition to classical atherosclerosis, arteriolipid abnormalities (except high density lipoprotein cholesterol ) emerged as independent risk markers may sclerosis (defined as purely obstructive sclerosis with frequent calcification, involving the whole arterial tree) be due to the aggressive treatments that were administered systematically against those abnormalities. appears to be a key component of arterial disease in chronic renal failure [10] . Arteriosclerosis may result Unfortunately, the duration of dialysis before transplantation, a potentially influential factor, was not from distinct mechanisms, such as increased glycation of arterial and plasma proteins, initiated by the chronic taken into account in those analyses. Except for diabetes, the disease responsible for chronic renal failure loss of renal function [11] .
Dialysis by itself appears to promote the development had no sizeable effect on the arterial risk.
Systemic arterial disease observed after renal trans-of arterial disease [7] . The risk factors involved here, such as the dose of haemodialysis [7] or associated lipid plantation is thus to be considered mainly as a consequence of the long period of chronic renal disorders [9], should be carefully identified to develop effective prevention. Alternatively, renal transplantation insufficiency that preceded transplantation. After transplantation, the only aggravating factor that could may have to be performed as early as possible following the onset of chronic renal failure. Nonetheless, the intervene is the intensity of immunosuppression. In the two studies published by Kasiske [1, 2] (conducted arterial pros and cons of such an aggressive strategy should first be thoroughly assessed and discussed. before and after the availability of cyclosporin), the level of immunosuppression, expressed as the number of acute rejection episodes, had only a modest influence References on the incidence of arterial disease. Many studies suggest that immune mechanisms are involved in the
